Delcath Systems Inc (DCTH)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $714.89M
Last updated: Nov 17, 2026 at 11:03 AM ET
Delcath Systems Inc (DCTH) P/E Ratio & Valuation History
Delcath Systems (DCTH) trades at 124.2x trailing earnings and 6.5x sales. Its P/S of 6.5x is below its 5-year median of 11.4x. Its forward P/E is 312.5x. The median P/E across 5 similar companies is 11.9x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 60.3% lower over the next year. Its free cash flow yield is 2.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 124.2x |
| Forward P/E | 312.5x |
| Price to sales | 6.5x |
| Price to book | 5.4x |
| EV/EBITDA | 149.1x |
| Price to FCF | 35.6x |
| EV/FCF | 32.9x |
| PEG | 1.6 |
| FCF yield | 2.8% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 6.5x | 11.4x | N/A |
Valuation History
Over the 6 of the 10 year ends shown that have a P/S, its P/S ranged from 4.1x in 2020 to 30.0x in 2023.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $10.10 | 144.3x | 4.3x | 3.6x |
| 2024 | $12.04 | N/A | 9.1x | 5.0x |
| 2023 | $4.16 | N/A | 30.0x | 6.1x |
| 2022 | $3.60 | N/A | 11.7x | N/A |
| 2021 | $7.75 | N/A | 16.2x | 5.1x |
| 2020 | $17.92 | N/A | 4.1x | 4.0x |
| 2019 | $21.25 | N/A | N/A | N/A |
| 2018 | $200.07 | 61.9x | N/A | N/A |
| 2017 | $32,142.86 | N/A | N/A | N/A |
| 2016 | $113,300,492.61 | N/A | N/A | 88.3x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DCTH
What is DCTH's forward P/E ratio?
Delcath Systems has a forward P/E ratio of 312.5x.
Is DCTH stock overvalued?
GNG's valuation label for DCTH is Fairly valued. Its P/E of 124.2x compares with a median of 11.9x across 5 similar companies.
What is DCTH's price to sales ratio?
Delcath Systems has a price to sales ratio of 6.5x.
What is DCTH's PEG ratio?
Delcath Systems has a PEG ratio of 1.6.
DCTH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors